Kodiak Sciences (KOD)
(Delayed Data from NSDQ)
$3.01 USD
-0.14 (-4.44%)
Updated Jun 6, 2024 04:00 PM ET
After-Market: $3.01 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Brokerage Reports
Kodiak Sciences Inc. [KOD]
Reports for Purchase
Showing records 121 - 127 ( 127 total )
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Our Presenting Companies at the ROTH Conference and 2020 Catalyst Calendar
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Our Presenting Companies at the ROTH Conference and 2020 Catalyst Calendar
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
KSI-301 Shows Increasing Durability While Maintaining Competitive Efficacy
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
Company: Kodiak Sciences Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and $115 PT
Provider: Roth Capital Partners, Inc.
Analyst: JALLAH Z